About this episode
Personalised vaccines could offer a breakthrough in the fight against cancer. Our correspondent analyses the latest trial. Canada’s oil market is flourishing, despite the trade war. And, why we will always love Dolly Parton.
Guests and host:
- Natasha Loder, health editor
- Sarah Lawrynuik, deputy editor of “The Intelligence”
- Jon Fasman, senior culture correspondent
- Jason Palmer, co-host of “The Intelligence”
Topics covered:
- Cancer, immunotherapy, vaccines, mRNA
- Oil, Canada, trade war, tariffs
- Dolly Parton, country music
Listen to what matters most, from global politics and business to science and technology—subscribe to The Economist.
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time Economist Podcasts publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Economist Podcasts
Bargaining chips: Nvidia is the bank of AI
Economist Podcasts
Ire and ICE: the toll of America’s deportations
Economist Podcasts
Right in front: AfD could win German state
Economist Podcasts
After the flood: Nepal’s ongoing rescue
Economist Podcasts